Tatva Chintan Pharma Chem Ltd vs Veedol Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 1122 as of 23 Mar 16:01 . The P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 yearsThe P/E Ratio of Veedol Corporation Ltd changed from 10.4 on March 2021 to 13.8 on March 2025 . This represents a CAGR of 5.82% over 5 years The Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 yearsThe Market Cap of Veedol Corporation Ltd changed from ₹ 1507 crore on March 2021 to ₹ 2379 crore on March 2025 . This represents a CAGR of 9.56% over 5 years The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The revenue of Veedol Corporation Ltd for the Dec '25 is ₹ 550.84 crore as compare to the Sep '25 revenue of ₹ 520.18 crore. This represent the growth of 5.89% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The ebitda of Veedol Corporation Ltd for the Dec '25 is ₹ 64.7 crore as compare to the Sep '25 ebitda of ₹ 64.02 crore. This represent the growth of 1.06% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The net profit of Veedol Corporation Ltd changed from ₹ 37.11 crore to ₹ 43.55 crore over 7 quarters. This represents a CAGR of 9.58% The Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 yearsThe Dividend Payout of Veedol Corporation Ltd changed from 86.85 % on March 2021 to 73.51 % on March 2025 . This represents a CAGR of -3.28% over 5 years .

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

About Veedol Corporation Ltd

Veedol Corporation Limited was incorporated on 26th October, 1921 under the name Eastern Oil Products, Limited' and subsequently under the order of the Government of Bengal, with effect from 11th January, 1928, the entity had been rechristened as Tide Water Oil Co. (India), Ltd.' Thereafter, the name of the Company was changed to Veedol Corporation Limited' on September 20, 2024. Veedol Corporation is a part of the multi divisional Andrew Yule group that has diverse interests in Engineering, Electrical, Tea Cultivation, Power Generation, Digital Communication Systems and Lubricants.
The company manufactures and sells engine lubricants for the automotive and industrial applications in India.
The company's plants are set up in Howrah, Royapuram, Turbhe, Silvassa and Faridabad. The company offers various automotive oils, such as diesel engine, premium diesel engine, PMCO and two wheeler, dedicated engine, gear and transmission, and agri engine oils, as well as coolant and brake fluid; and industrial oils comprising general purpose machinery, spindle, turbine, hydraulic and circulation, heavy duty hydraulic, steam cylinder, industrial gear, cutting, non drip, and mill roll oils.

FAQs for the comparison of Tatva Chintan Pharma Chem Ltd and Veedol Corporation Ltd

Which company has a larger market capitalization, Tatva Chintan Pharma Chem Ltd or Veedol Corporation Ltd?

Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr while Market cap of Veedol Corporation Ltd is 2,320 Cr

What are the key factors driving the stock performance of Tatva Chintan Pharma Chem Ltd and Veedol Corporation Ltd?

The stock performance of Tatva Chintan Pharma Chem Ltd and Veedol Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tatva Chintan Pharma Chem Ltd and Veedol Corporation Ltd?

As of March 23, 2026, the Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45. On the other hand, Veedol Corporation Ltd stock price is INR ₹1332.0.

How do dividend payouts of Tatva Chintan Pharma Chem Ltd and Veedol Corporation Ltd compare?

To compare the dividend payouts of Tatva Chintan Pharma Chem Ltd and Veedol Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.